Clinical trial
The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]
NCT02688894 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 10, 2016
- Completion date
- December 31, 2028
- Enrollment
- 797 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
neuroendocrine carcinoma, small cell lung cancers